At first glance, Novo Nordisk (NYSE:NVO) doesn't appear at all enticing. Down roughly 11% in the trailing month, NVO stock has been a victim of broader market pressure. But it's also the red ink that ...
Hosted on MSN
Did Eli Lilly Just Say "Checkmate" to Novo Nordisk?
Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly's recent clinical progress sets it up for another critical approval. The company has fantastic ...
Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly's recent clinical progress sets it up for another critical approval. The company has fantastic ...
A news special on Britain’s Channel 4 titled “Will AI Take My Job?” investigated how automation is reshaping the workplace and pitting humans against machines. At the end of the hour-long program, a ...
Palantir cofounder and libertarian tech billionaire Peter Thiel has been giving a series of secret lectures about technology and religion, which centered on his theories about the antichrist — yes, ...
All products featured on WIRED are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. Learn more. But ...
CNN on Friday admitted that a technical issue was the cause of an awkward on-air exchange between anchor John Berman and Rep. Mike Lawler (R-NY). The day before, Lawler appeared on CNN to discuss ...
Google is pushing an update for its Pixel Buds Pro 2. New features include adaptive audio and head gesture support. The features should arrive over the next few weeks. If you own Pixel Buds Pro 2, you ...
Weight-loss drugmaker to cut 11.5% of staff 5,000 job cuts in home country of Denmark Expects annual savings of $1.3 billion Will boost performance-based culture, CEO says Shares up 2.1% The ...
JBL just announced the PartyBox 720, which is an extremely chonky party speaker. As a matter of fact, it's the company's largest-ever battery-powered party speaker. The thing is bigger than many human ...
Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to patients who pay for the medications with cash. Starting this week, customers ...
On this episode of Stock Movers: - Novo Nordisk (NVO) shares rise after news that it's slashing the cost of Ozempic for cash-paying patients to $499 a month through NovoCare and partnering with GoodRx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback